AI
JAZZ icon

Atria Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atria Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$598K Sell
3,164
-1,405
-31% -$246K 0.01% 1347
2025
Q4 		$777K Sell
4,569
-275
-6% -$42.2K 0.01% 1206
2025
Q3 		$638K Buy
4,844
+1,556
+47% +$187K 0.01% 1295
2025
Q2 		$349K Buy
3,288
+34
+1% +$3.69K ﹤0.01% 1624
2025
Q1 		$404K Buy
3,254
+522
+19% +$68.1K 0.01% 1467
2024
Q4 		$336K Buy
2,732
+445
+19% +$52.4K ﹤0.01% 1539
2024
Q3 		$255K Sell
2,287
-8
-0.3% -$877 ﹤0.01% 1698
2024
Q2 		$245K Buy
+2,295
New +$252K ﹤0.01% 1706
2020
Q1 		– Sell
-1,419
Closed -$212K – 886
2019
Q4 		$212K Buy
+1,419
New +$193K 0.01% 1129
2019
Q1 		– Sell
-2,743
Closed -$340K – 989
2018
Q4 		$340K Sell
2,743
-587
-18% -$87.1K 0.02% 618
2018
Q3 		$560K Sell
3,330
-446
-12% -$76.7K 0.02% 561
2018
Q2 		$651K Buy
+3,776
New +$617K 0.03% 490
2014
Q4 		– Sell
-1,304
Closed -$209K – 441
2014
Q3 		$209K Buy
+1,304
New +$200K 0.02% 433
2014
Q1 		– Sell
-1,635
Closed -$207K – 446
2013
Q4 		$207K Buy
+1,635
New +$169K 0.02% 429

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Atria Investments's JAZZ Position: Q1 2026 in Review

Atria Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 31% in Q1 2026, selling an estimated $246K and leaving 3,164 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #1347.

Atria Investments first reported a position in JAZZ in Q4 2013 and has held it in 14 quarters since. The position peaked at $777K in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Atria Investments held 3,164 shares of Jazz Pharmaceuticals worth $598K as of Q1 2026.
  • Atria Investments sold 1,405 Jazz Pharmaceuticals shares in Q1 2026, an estimated $246K.
  • Jazz Pharmaceuticals made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1347 holding.
  • Atria Investments first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 14 quarters since.
  • Atria Investments's Jazz Pharmaceuticals position peaked at $777K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.